Search

…of antibody libraries that are key to understanding an antibody’s mechanism of action and can guide the library-to-leads triage. Here, we sought to compare the binding kinetics obtained on two…

Presented by: As a disease of misregulation, cancer is characterized both genetically and proteomically, requiring high quality tools to dissect the change difference between cell states. Among the reagents used…

…to enrich LENSai™. VICTORIA, BRITISH COLUMBIA (CANADA), March 19, 2024 – IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today…

Carterra Ultra™ Drug Discovery Platform Disruptive technology for the characterization of small molecules and fragments With enhanced sensitivity, expanded thermal options, and advanced microfluidics, the Carterra Ultra™ platform is our…

Discovery on Target 2023 – Boston…

SLAS 2024 – Boston…

…and HTP experimentation to engineer biologics Abstract: This talk will cover our efforts to combine computational modeling, HTP protein-protein interaction assays, and biophysical characterization to engineering improved biologics. View the…

…be triaged efficiently. DELs are made combinatorically, with every library member being assigned a unique DNA barcode, and every step of chemistry being compatible with the presence of DNA. Here,…

…map the epitope landscape on the SARS-CoV-2 Spike, defining and structurally illustrating seven receptor-binding domain (RBD)-directed antibody communities with distinct footprints and competition profiles. Pseudovirion-based neutralization assays reveal Spike mutations,…